Vanda Pharmaceuticals Enters into an Exclusive Global License Agreement with AnaptysBio to Develop and Commercialize Imsidolimab
Shots: Vanda received exclusive rights to develop, manufacture & commercialize...
Bayer Submits MAA of Finerenone to the EMA for Heart Failure (HF)
Shots: The EMA received MAA of finerenone for HF pts having a left ventricular eje...
Jupiter Neurosciences Collaborates with Zina Biopharmaceuticals to Advance Jotrol in P-II Trial for Parkinson’s Disease
Shots: Jupiter has partnered with Zina to support its P-IIa trial of Jotrol for as...
Siolta Therapeutics Enters into a Joint Research Agreement with Cowellnex
Shots: Siolta Therapeutics has entered into a preclinical research partnership wit...
Neurocrine Biosciences and Takeda Amend Partnership to Develop and Commercialize Osavampator in Japan
Shots: Neurocrine & Takeda have revised their 2020 collaboration to develop &a...
Cstone Join Forces with SteinCares to Commercialize Sugemalimab in 10 Latin American Countries
Shots: CStone & SteinCares have partnered to commercialize sugemalimab, where...
